Perry Maxwell

Dr. Perry Maxwell is Clinical and Scientific Lead at the Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, where he directs research at the intersection of AI and clinical pathology. His work focuses on developing AI-driven diagnostic tools for cancer, molecular profiling, and tissue-based analytics.

Research interests center on digital pathology innovation, particularly AI applications in immunohistochemistry, cancer mutation prediction (e.g., KRAS), and T-cell response quantification. His translational work bridges computational models with clinical adoption pathways.

Recent publications (104 total) demonstrate:

• Dominant focus on AI-powered cancer diagnostics (2023-2024)
• Integration of vision transformers for histopathological analysis
• Clinical validation studies for tissue-based algorithms

He leads academic collaborations, hosting international visitors (2019-2023) and contributing to public science communication, including the 2022 PGJCCR Cancer Digest on digital pathology.